208 related articles for article (PubMed ID: 3876442)
1. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
[TBL] [Abstract][Full Text] [Related]
2. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Castagnoli N; Chiba K; Trevor AJ
Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243
[TBL] [Abstract][Full Text] [Related]
3. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
[TBL] [Abstract][Full Text] [Related]
5. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.
Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N
Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
Singer TP; Salach JI; Castagnoli N; Trevor A
Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
[TBL] [Abstract][Full Text] [Related]
7. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
Trevor AJ; Singer TP; Ramsay RR; Castagnoli N
J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions.
Weissman J; Trevor A; Chiba K; Peterson LA; Caldera P; Castagnoli N; Baillie T
J Med Chem; 1985 Aug; 28(8):997-1001. PubMed ID: 3874963
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
10. Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Gessner W; Brossi A; Shen RS; Abell CW
FEBS Lett; 1985 Apr; 183(2):345-8. PubMed ID: 3872811
[TBL] [Abstract][Full Text] [Related]
11. The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Trevor AJ; Castagnoli N; Singer TP
Toxicology; 1988 May; 49(2-3):513-9. PubMed ID: 3287698
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites.
Cashman JR
Toxicology; 1987 Feb; 43(2):173-82. PubMed ID: 2949395
[TBL] [Abstract][Full Text] [Related]
13. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
Ottoboni S; Caldera P; Trevor A; Castagnoli N
J Biol Chem; 1989 Aug; 264(23):13684-8. PubMed ID: 2788162
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
15. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
Shi H; Noguchi N; Xu Y; Niki E
FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation.
Hiebert CK; Sayre LM; Silverman RB
J Biol Chem; 1989 Dec; 264(36):21516-21. PubMed ID: 2600079
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.
Wu EY; Chiba K; Trevor AJ; Castagnoli N
Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
[TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
